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  To the patients with benign prostatic hypertrophy， 59 to 84 in age， one tablet bf chlormadinone
acetate 25 mg tablet （Prostal＠） was orally administered twice a day． The treatment was performed
for 16 weeks and the ’foliowing results were obtained．
1． The clinical efficacy was observed in 14 cases out of 20 cases （709／0）． There was no case in whom
 the symptom was aggravated．
2． The improvement in subjective symptoms wa，s observed in 13 cases out of 20 cases （65e／．）．
3． The improvement in objective findings was observed in 14 cases out of 20 cases （700／．）． The im－
 provement was also proved in residual urine volume， maximum fiow rate， residual rate and UCG
 in 17 cases out of 20 cases （859／6）， 13 cases out of 19 cases （680／6）， 12 cases out of 19 c4ses （63％）
 and 13’ cases out of 16 cases （810／o）， respectively，
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4． General blood test， liver function test and kidney function test were all normal except for one case
 of gastric u正cer in which general b正ood亡es亡at the亡imc．of completion of the treatment was found
to be alDteredDrrpore ’than 1．0．0／． in comparison yith the．pretreatrpent value． ？vl．： reoy． gr， at thg
 completion of the treatment， even a transient increase in the kidney functibn’test Was’ observed
 in another case． However， there has been observed no other obvious infiuence．，
  From these results as’mentioned above， chlormadinone acetate 25 mg tablet （Prostal＠） was





























 前記の対象症例に対してCMA 25 mg錠を1回1
錠，lEI2回服用，16週問の継続投与を行なった．ま
た治験期間中は抗生物質，消炎剤を原則として投与せ
Table 1． Clinical cases treated with CMA
Case No．
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Table 2． lmprovement of subjective symptoms
























































＊e： unchanged 1： one rank improvement 2： two rank improvement
Table 3． Results of rectal palpation and uroflowmetry





















Table 4．Improvement on findings of
urofiowmetry
Table 5．Improvement on findings of
urethrocystogram
























































Fig． 1． Case No． 6， 1．K． 67 Y．
      （A） before treatment． （B） after treatment， prostatic








Case No． 17， H．K． 81 Y．
（A） before treatment． （B） after treatment， prostatic
protrusion into the bladder was markedly decreased．
Tab且e 6．Comparison of blood examinations between before and after treatment
ExarninationChanges within 109（e


































































Table 7．Comparison of serum biochemica1 and electrolyte examinations
between before and after treatment
ExaminationChanges within 20cro














18 （1 00 90）
11 （1 00 90）
8．（ 44％）
11 （ 6190）















2 （1 1 ero）
5 （2890）
1（ 690）














Table 8． Clinical eMcacy of chlormadinone acetate for benign prostatic hypertrophy
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